180 Life Sciences (ATNF)
搜索文档
180 Life Sciences (ATNF) - 2020 Q3 - Quarterly Report
2020-11-24 09:47
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 180 LIFE SCIENCES CORP. | --- | --- | |---------------------------------------------------|--------------------------------- ...
180 Life Sciences (ATNF) - 2020 Q2 - Quarterly Report
2020-08-20 05:41
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 | --- | --- | |----------------------------------------------------------------------------|------------------------------------- ...
180 Life Sciences (ATNF) - 2020 Q1 - Quarterly Report
2020-05-23 04:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------------------- ...
180 Life Sciences (ATNF) - 2019 Q4 - Annual Report
2020-04-08 05:04
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | |-------------------------------------------------------- ...
180 Life Sciences (ATNF) - 2019 Q3 - Quarterly Report
2019-11-13 06:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | |---------------------------------------- ...
180 Life Sciences (ATNF) - 2019 Q2 - Quarterly Report
2019-08-10 04:44
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | |-----------------------------------------| | ...
180 Life Sciences (ATNF) - 2019 Q1 - Quarterly Report
2019-05-14 02:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-38105 KBL MERGER CORP. IV (Exact name of registrant as specified in its charter) | --- | --- | |-------------------------------------- ...
180 Life Sciences (ATNF) - 2018 Q4 - Annual Report
2019-04-02 05:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class: Name of Each Exchange on Which Registered: Common Stock, par value $0.0001 per share The NASDAQ Stock Market LLC Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $5.75 per half share The NASDAQ Stock Market LLC Rights, exchangeable into one-tenth of one share of Common Stock The NASDAQ Stock Market LLC Units, each consisting of one share of Common Stock, one Warran ...